Comparative Study to Assess an Advanced Skin Protectant in the Management of Incontinence-associated Dermatitis
Effects of an Advanced Skin Protectant in the Management of Incontinence-associated Dermatitis Compared to Hospital Standard Care Practice: an Exploratory Randomized Controlled Trial
Sponsor: 3M
This NA trial investigates Incontinence-associated Dermatitis and is currently terminated or withdrawn. 3M leads this study, which shows 14 recorded versions since 2017 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
14 versions recorded-
Sep 2025 — Present [monthly]
Terminated NA
-
Dec 2024 — Sep 2025 [monthly]
Terminated NA
-
Sep 2024 — Dec 2024 [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Jan 2023 — Jul 2024 [monthly]
Terminated NA
▶ Show 9 earlier versions
-
Dec 2022 — Jan 2023 [monthly]
Terminated NA
-
Dec 2021 — Dec 2022 [monthly]
Terminated NA
-
Jan 2021 — Dec 2021 [monthly]
Terminated NA
-
Feb 2020 — Jan 2021 [monthly]
Terminated NA
-
Oct 2019 — Feb 2020 [monthly]
Terminated NA
-
Jan 2019 — Oct 2019 [monthly]
Terminated NA
Status: Recruiting → Terminated
-
Jun 2018 — Jan 2019 [monthly]
Recruiting NA
-
Dec 2017 — Jun 2018 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Oct 2017 — Dec 2017 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- 3M
- Solventum US LLC
For direct contact, visit the study record on ClinicalTrials.gov .